Under pressure to score a win before the symbolic 100-day mark, the administration tried to revive their healthcare plan for a vote, as POTUS tried brinkmanship again to negotiate funding for the border wall. Neither happened.

However, the administration announced continuation of payments under the ACA’s cost-sharing reduction subsidies, estimated to be $7 Bn in 2017. This wasn’t enough for the health insurance sector, which has demanded a 2-year commitment. There are still several aspects of the proposed new plan that could weaken consumer protection and increase premiums in some states.

A feud between the largest PBM and a health insurance giant opens the kimono a bit to reveal whose drug sales profits are bigger. A subtext to the story is how even the largest companies can be exposed to client concentration risks – a familiar problem in the tech sector.

Four years back, Google’s Verily Life Sciences set out to “defeat mother nature” by claiming to build a Star Trek-style tricorder. Today, they are – verily – a bit more grounded. Their latest – a longitudinal study for which they are recruiting 10,000 participants who will basically give up all privacy for 4 years to make a contribution to science and medicine.

Healthcare may be the best placed to take advantage of new technologies like AI and blockchain. IBM Watson Health has published an interesting study on the use of deep learning and neural networks for analyzing images for diabetic retinopathy, and the Dean of Stanford Med School declares that algorithms will drive future health gains.

However, the prospects for new technologies may be a bit overstated, if you look at VC funding data and surveys that indicate disconnects even within healthcare about adopting new technologies and care delivery models. I discuss these misalignments in my latest blog in CIO online.

It pays well to be a doctor – unless you’re a woman in some states. Find out where the highest gender wage gaps are.

Sign up for our newsletter The Healthcare Leader